Econ Ink cover Spring 2026
Featured publication

Tracking the developments in the fields of law and economics, public policy, and business strategy.

SPRING 2026

View Issue

Search Insights

Latest Insights

See All Insights

Events

ABA Forum on Construction Law Annual Meeting

May 6, 2026 – May 9, 2026

We’re excited to sponsor the ABA Forum on Construction Law Annual Meeting, May 6–9 in Chicago. Managing Director Meera Wagman will be speaking on Wednesday, May 6 as part of the practicum session: “Forensic Tools for Post-Mortem Review and Litigation Support”.

Read More

DKN Networks 13th Annual Litigation Summit

April 21, 2026 – April 22, 2026

Secretariat is proud to sponsor the DKN Networks 13th Annual Litigation Summit, taking place April 21–22 in Berlin. Dr. Björn Brand will be hosting the summit, bringing together leading voices from across the litigation and arbitration landscape.

Read More

ACFE Singapore Fraud Conference 2026

April 15, 2026 – April 16, 2026

Anna Bleazard, Managing Director, and Kien Chung Hoo, Associate Director, will be speaking at the ACFE Singapore Fraud Conference 2026, presenting a session titled “Regulatory expectations on AI use in Compliance and Investigations”.

Read More
See All Events
featured Engagements

Eric Poer Reflects on a Historic Forensic Investigation That Drove Sweeping Reforms at Wells Fargo in the Wake of Historic Fraud Scandal 

Eric Poer, an internationally-recognized forensic accounting, investigations, and disputes expert, led the forensic accounting and data analytics team retained to support A&O Shearman in conducting an independent investigation into Wells Fargo’s sales practices—an inquiry launched in response to one of the most significant financial consumer fraud scandals in U.S. history.

Read More
View All Engagements
featured Engagements

Biopharmaceutical Reasonable Royalties on Trial

When our client, a biopharmaceutical company, had exclusively licensed a patent for a novel type of cancer immunotherapy, a competitor undertook substantial efforts to be first to market for its lead indication despite being aware of potential infringement claims against its therapy. Upon the competitor achieving FDA approval, our client filed patent infringement claims. After an eight-day trial, the jury returned a verdict in favor of our client with a damages award that precisely matched the trial testimony.

Read More
View All Engagements

Media Contact

If you would like to schedule an interview or would like more information about our firm and individual experts, please contact:

Nathan Jenks
Director of Marketing & Communications
Email: njenks@secretariat-intl.com